3 reports

R& D Progress Research and Development Brief Company reported that the drug candidate has demonstrated superior activity in tumors where PD-## monotherapy or PD-##/ LAG-## monoclonal antibody combo has shown activity.

  • Immunotherapy
  • Monoclonal Antibody
  • Research And Development
  • Therapy
  • MacroGenics, Inc.
  • Aurigene Discovery Technologies Limited - Research and Development Overview
  • Drugs to Target Fab Pathway for Gram Negative Bacterial Infections

R& D Progress Research and Development Brief Product Description Drugs to Inhibit MALT-## for Oncology and Inflammation Drugs are under development for the treatment of cancer and inflammation.

  • Oncology
  • Research And Development
  • World
  • Company Operations
  • Aurigene Discovery Technologies Limited
  • Bolder Biotechnology, Inc. - Research and Development Overview
  • BBT-059

Other Developmental Activities R& D Progress Research and Development Brief Other Developmental Activities Bolder Biotechnology, Inc. - Pipeline Analysis Bolder Biotechnology, Inc. - Pipeline Products by Target Bolder Biotechnology, Inc. - Pipeline by Target, 2016 Bolder Biotech

  • Medical Biotechnology
  • Protein Therapy
  • Research And Development
  • United States
  • Bolder BioTechnology, Inc.